Charts for Quick CASH $$$ Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Charts for Quick CASH $$$

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Galirayo who wrote (7613)	5/4/1998 2:24:00 AM
From: John Metcalf	Read Replies (2) of 9262

Rick Harmon had an article on angiogenesis on Microsoft Investor. It doesn't seem to be available anymore. The companies named in the article were SUGN, GNE, IMCL, SCIO, REGN, RGEN, AGPH, and ENMD. SUGN is probably the best bet for a sympathy move with ENMD. ENMD might be favored for longer horizons, because of its partnership with BMY, and because Dr. Folkman is a leader in angiogenesis. I don't know the status of the VGEF program at Agouron. Hopefully, Rick will have something to add -- he has published on the subject.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next